当前位置: 首页 > 期刊 > 《中医药临床杂志》 > 2012年第1期
编号:12205290
HBME-1、CK19、Galectin-3、34βE12在甲状腺微小乳头状癌中的表达(2)
http://www.100md.com 2012年1月1日 《中国中医药咨讯》 2012年第1期
     [3] PIERSANTI M,EZZAT S,ASA SL.Controversies inpapillary microcarci-noma thyroid[J].EndocrPathol,2003,14:183.

    [4] de Matos P S,Ferreira A P,de Oliverira Facuri F, et al. Usefulness

    of HBME-1,cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid m alignancy[J]. Histopathology,2005,47( 4) : 391 - 401

    [5] Nasser, SM, Pitman,MB, Pilch, BZ, et a.l Fine-needle aspiration bi-

    opsy ofpapillary thyroid carcinoma: diagnostic utility of cytokeratin19 immunostaining[J].Cancer, 2000, 90(5): 307-311.

    [6]Rossi ED, Raffaelli M, Mule`A, et al. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid[J]. Histopathology,2006, 48(7): 795- 800

    [7] KawachiK, Matsushita Y, Yonezawa S,et al. Galectin-3 expression in various thyroid neoplasms and its possible role inmetastasis formation[J]. Hum Patho,l 2000, 31: 428-433

    [8] Liberman E,Weidner N. Papillary and follicular neoplasms of the thyroid gland: Differential immunohistochemical staining with highmolecular-weightkeratin and involucrin[J].Appl Immunoshitochem MolMorpho,l 2000, 8(1): 42-48, 百拇医药(李丽 崔俊生 孔庆杨)
上一页1 2